Literature DB >> 9442313

Polymorphism in glutathione S-transferase loci as a risk factor for common cancers.

R C Strange1, J T Lear, A A Fryer.   

Abstract

Though a developing body of data indicates polymorphism at GST genes influences cancer susceptibility, it is unclear why a genotype is associated with one cancer but not another. We believe the GST exert a critical role in normal cell house-keeping activities. GSTM1, GSTM3 and GSTT1 influence tumorigenesis because these enzymes utilise the products of UV-induced oxidative stress. Further support for the importance of these genes in the protection of skin from UV comes from studies in systemic lupus erythematosus (Ollier et al, 1996). Thus, GSTM1 null is associated with increased anti-Ro (but not anti-La) antibodies, a phenotype associated with photosensitivity. At present there is no basis for predicting which cancers will be influenced by GST polymorphisms though other studies do indicate that the GSTs are critical in the metabolism of environmental carcinogens. For example, GSTT1 null confers an increased risk of astrocytoma (Hand et al, 1996). While brain tumours are not clearly associated with environmental pollutants, N-methyl-N-nitrosourea, processed meats and occupation have been implicated. Why GSTT1 but not GSTM1 or GSTM3 influences the risk of astrocytoma is unclear. GSTM3 appears a good susceptibility candidate, as some astrocytes demonstrate strong expression (Hand et al, 1996). Susceptibility to squamous cell cancer of the larynx, a pathology associated with chronic consumption of tobacco and alcohol, is also influenced by allelism at GSTM3 (Jahnke et al, 1996). The roles of CYP2D6 and CYP1A1 are even more unclear, though the finding that systemic agents such as arsenic predispose to multiple BCC, suggests that CYP2D6-mediated hepatic detoxification of photosensitizing agents may be important. Importantly, the extent of altered risk conferred by genotypes is generally 2-3 fold and it is necessary to identify which other genes interact with the GST so that haplotypes associated with 10-20 fold increases in risk can be defined.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9442313     DOI: 10.1007/978-3-642-46856-8_37

Source DB:  PubMed          Journal:  Arch Toxicol Suppl        ISSN: 0171-9750


  5 in total

1.  Contribution of glutathione S-transferase gene polymorphisms to development of skin cancer.

Authors:  Zeyuan Lei; Ting Liu; Xiang Li; Xiaoxia Xu; Dongli Fan
Journal:  Int J Clin Exp Med       Date:  2015-01-15

2.  An association between BPDE-like DNA adduct levels and CYP1A1 and GSTM1 polymorphisma in pterygium.

Authors:  Jai-Nien Tung; Heng-Hsiung Wu; Chun-Chi Chiang; Yi-Yu Tsai; Ming-Chih Chou; Huei Lee; Ya-Wen Cheng
Journal:  Mol Vis       Date:  2010-04-08       Impact factor: 2.367

3.  CYP1A1 gene polymorphisms as a risk factor for pterygium.

Authors:  Chi-Hsien Young; Yu-Lun Lo; Yi-Yu Tsai; Tung-Sheng Shih; Huei Lee; Ya-Wen Cheng
Journal:  Mol Vis       Date:  2010-06-09       Impact factor: 2.367

4.  Immunohistochemical markers for prognosis of cerebral glioblastomas.

Authors:  Andrey Korshunov; Andrey Golanov; Regina Sycheva
Journal:  J Neurooncol       Date:  2002-07       Impact factor: 4.130

5.  A 6-bp Deletion Variant in a Novel Canine Glutathione-S-Transferase Gene (GSTT5) Leads to Loss of Enzyme Function.

Authors:  S Craft; J Ekena; J Sacco; K Luethcke; L Trepanier
Journal:  J Vet Intern Med       Date:  2017-11-03       Impact factor: 3.333

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.